Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2005-10-25
2005-10-25
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001110, C424S001650, C534S014000
Reexamination Certificate
active
06958141
ABSTRACT:
Novel methods, processes and metal complexes attached to a hypoxia-localizing moiety comprisinga metal, preferably radionuclide of rhenium or technetium;a hypoxia-localizing moiety; and,a complexing ligand, wherein said ligand and said radionuclide combined have cell membrane permeabilities greater than that of sucrose, are disclosed.
REFERENCES:
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4789736 (1988-12-01), Canning et al.
patent: 4818813 (1989-04-01), Nowotnik et al.
patent: 5037631 (1991-08-01), Nosco
patent: 5608110 (1997-03-01), Ramalingam et al.
patent: 5651954 (1997-07-01), Nowotnik et al.
patent: 5665329 (1997-09-01), Ramalingam et al.
patent: 5808091 (1998-09-01), Linder et al.
patent: 6184361 (2001-02-01), Linder et al.
patent: 6359120 (2002-03-01), Linder et al.
patent: 6384232 (2002-05-01), Ramalingam
patent: 6699458 (2004-03-01), Linder et al.
patent: 92/12148 (1992-09-01), None
patent: 92/12147 (1994-08-01), None
patent: 2023595 (1994-04-01), None
patent: 4025788 (1992-03-01), None
patent: 441491 (1991-08-01), None
patent: 502594 (1992-09-01), None
patent: 502595 (1992-09-01), None
patent: 417870 (1994-04-01), None
patent: 89102182 (1990-10-01), None
patent: WO89/10759 (1989-11-01), None
patent: WO9118908 (1996-07-01), None
Chapman, J.D., Radiother. Oncol., vol. 19, 1991, pp. 13-19.
Martin, G.V., et al., Journal of Nuclear Medicine, vol. 30, No. 2, 1989, pp. 194-201.
Hoffman, J.M., et al., Stroke, vol. 18, 1987, pp. 168-176.
Koh, W.J., et al., Journal of Nuclear Medicine, vol. 30, 1989, p. 789.
Biskupiak, J.E., et al., J. Med. Chem., vol. 34, 1991, pp. 2165-2168.
Chapman, J.D., Cancer, vol. 54, No. 11, 1984, pp. 2411-2449.
Kedderis, G.L., et al., Drug. Metab. Reviews, vol. 19, 1988, pp. 33-62.
Adams, G.E., et al., Biochem. Pharmacol., vol. 35, No. 1. pp. 71-76, 1986.
Brown, D.M., et al., Rad. Res., vol. 90, 1982, pp. 98-108.
Adams, G.E., et al., Int. J. Radiat. Biol., vol. 35, No. 2, 1979, pp. 133-150.
Adams, G.E., et al., Int. J. Radiat. Biol., vol. 38, No. 6, 1980, pp. 613-626.
Jerabek, P.A., et al., Int. J. Appl. Radiat. Isotop., vol. 37, No. 7, 1986, pp. 599-605.
Martin, G.V., Circ. Res., vol. 67, 1990, pp. 240-244.
Shelton, M.E., et al., J. Amer. College Cardiology, vol. 16, No. 2, 1990, pp. 477-485.
Mannan, R.H., et al., Journal of Nuclear Medicine, vol. 32, 1991, pp. 1764-1770.
Parker, D., “Harnessing the Kinetic Stability of Macrocyclic Complexes in Vivo,” presented at the 16th Int. Symp. on Macrocyclic Chemistry, University of Sheffield, UK, Sep. 1-6, 1991.
Yang, L., et al., J. Med. Coll. of PLA, vol. 2, 1987, pp. 265-269.
Volkert, W.A., et al., Eur. J. Nucl. Med., vol. 9, 1984, pp. 511-516.
Kung, H.F., et al., Journal of Nuclear Medicine, vol. 25, 1984, pp. 326-332.
Lever, S.Z., et al., Journal of Nuclear Medicine, vol. 26, 1985, pp. 1287-1294.
DiRocco Richard J.
Linder Karen
Nowotnik David P.
Nunn Adrian D.
Pirro John P.
Bracco International B.V.
Jones Dameron L.
Kramer Levin Naftali & Frankel LLP
LandOfFree
Rhenium and technetium complexes containing a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rhenium and technetium complexes containing a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rhenium and technetium complexes containing a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3488708